The efficacy of laparoscopic indocyanine green sentinel lynph node mapping.

The efficacy of laparoscopic indocyanine green sentinel lynph node mapping. - The efficacy of laparoscopic indocyanine green sentinel lynph node mapping.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028953

Enrollment

Registered

2017-09-01

Start date

2017-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early Cervical Cancer and Endometrial Cancer

Interventions

ICG is injected at submucousa of uterine cervix during the operation.Sentimel lymoh nodes are identified with ICG camera system device and removed to histological investigation. After that, pelvic ly

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1)Patients with early Cervical Cancer stage IA2-IB1 and who chose laparoscopic operation. 2)Endometrial Cancer stage IA and who chose laparoscopic operation. 3)Patients who is diagnosed by histrogically. 4)Patiant without enlarged lymph nodes by MRI or CT.

Exclusion criteria

Exclusion criteria: 1)double cancer 2)allergy for indocyanine green or iodine 3)uncontrolled complication

Design outcomes

Primary

Measure	Time frame
Identification rate of laparoscopic indocyanine green sentinel lymph node mapping for early Cervical Cancer and Endometrial Cancer.	—

Countries

Japan

Contacts

Public ContactEiji Kondo

Mie University School of Medicine Department of Obstetrics and Gynecology

eijikon@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026